Gergely Varga

Budapest, BU, Hungary

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 38 publications

Mezigdomide, carfilzomib, and dexamethasone versus carfilzomib and dexamethasone in patients with relapsed or refractory multiple myeloma (SUCCESSOR-2): a phase 3, open-label, randomised controlled trial.

Mezigdomide, carfilzomib, and dexamethasone versus carfilzomib and dexamethasone in patients with relapsed or refractory multiple myeloma (SUCCESSOR-2): a phase 3, open-label, randomised controlled trial.

Journal: Lancet (London, England)

Published: April 29, 2026

Ixazomib-Lenalidomide-Dexamethasone for the Treatment of Relapsed/Refractory Multiple Myeloma: A Hungarian Real-World Analysis.

Ixazomib-Lenalidomide-Dexamethasone for the Treatment of Relapsed/Refractory Multiple Myeloma: A Hungarian Real-World Analysis.

Journal: Journal of clinical medicine

Published: December 01, 2025

Efficacy and Safety of Daratumumab, Lenalidomide and Dexamethasone Therapy in the First Relapse of Multiple Myeloma Patients - Real World Data from Hungary.

Efficacy and Safety of Daratumumab, Lenalidomide and Dexamethasone Therapy in the First Relapse of Multiple Myeloma Patients - Real World Data from Hungary.

Journal: Journal of hematology

Published: October 08, 2025

Two B or not two B; the question of bendamustine dosing in low grade lymphoma.

Two B or not two B; the question of bendamustine dosing in low grade lymphoma.

Journal: Pathology oncology research : POR

Published: June 11, 2025

Gastrointestinal amyloidosis - retrospective analysis based on data of a center in Budapest

Gastrointestinal amyloidosis - retrospective analysis based on data of a center in Budapest

Journal: Orvosi hetilap

Published: December 04, 2024

Changes in the treatment outcomes of light chain amyloidosis - findings of a large center in Budapest

Changes in the treatment outcomes of light chain amyloidosis - findings of a large center in Budapest

Journal: Orvosi hetilap

Published: August 14, 2024

Investigating the effect of immunomagnetic separation on the immunophenotype and viability of plasma cells in plasma cell disorders.

Investigating the effect of immunomagnetic separation on the immunophenotype and viability of plasma cells in plasma cell disorders.

Journal: Pathology oncology research : POR

Published: June 18, 2024

Survival of patients affected with multiple myeloma at the Department of Internal Medicine and Haematology of Semmelweis University

Survival of patients affected with multiple myeloma at the Department of Internal Medicine and Haematology of Semmelweis University

Journal: Orvosi hetilap

Published: June 15, 2024

Assessment of anxiety, depression, and physical symptoms and understanding of their connections among cancer patients

Assessment of anxiety, depression, and physical symptoms and understanding of their connections among cancer patients

Journal: Orvosi hetilap

Published: December 04, 2023

How did the survival of acute myeloid leukemia change over the last ten years in our unit?

How did the survival of acute myeloid leukemia change over the last ten years in our unit?

Journal: Orvosi hetilap

Published: July 27, 2023

Evaluation of Retinal Blood Flow in Patients with Monoclonal Gammopathy Using OCT Angiography.

Evaluation of Retinal Blood Flow in Patients with Monoclonal Gammopathy Using OCT Angiography.

Journal: Journal of clinical medicine

Published: June 30, 2023

Outcome of Second Primary Malignancies Developing in Multiple Myeloma Patients.

Outcome of Second Primary Malignancies Developing in Multiple Myeloma Patients.

Journal: Cancers

Published: June 11, 2023

Showing 1-12 of 38

Last Updated: 09/26/2026